Best deals to access real time data! |
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals, Inc. (delisted) | ARIA | NASDAQ | Common Stock | US04033A1007 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 23.99 | - | - | - | 23.99 | 02:05:03 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 23.8 | 22.88 | -0.92 | -4.02% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
| Industry Sector |
|---|
| Biotechnology |
Ariad Pharmaceuticals, Inc. (delisted) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 4.66B | 194.2M | $ -231.16M | -1.23 | 0.00 | 157.76M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 161.07k | 91.70% |
Ariad Pharmaceuticals, Inc. (delisted) News
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) • Fri Apr 07, 2017 3:23 PM (6 months ago)
Confidential Treatment Order (ct Order) Edgar (US Regulatory) • Mon Feb 27, 2017 3:09 PM (7 months ago)
Termination of Registration of a Class of Security Under Section 12(b) (15-12b) Edgar (US Regulatory) • Mon Feb 27, 2017 10:30 AM (7 months ago)
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) • Tue Feb 21, 2017 11:19 AM (7 months ago)
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) • Thu Feb 16, 2017 4:54 PM (7 months ago)
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) • Thu Feb 16, 2017 4:51 PM (7 months ago)
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) • Thu Feb 16, 2017 4:48 PM (7 months ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARIA Price Data
There is no data to display
Ariad Pharmaceuticals, Inc. (delisted) Description
| Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. |
